Variant report
Variant | nsv900768 |
---|---|
Chromosome Location | chr13:87116479-87204838 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLITRK6-13 | chr13:87121092-87121529 | l_895_chr13:87064439-87121529_brain |
2 | lnc-SLITRK6-13 | chr13:87121092-87121219 | NONHSAT034575 |
3 | lnc-SLITRK6-13 | chr13:87121092-87121515 | NONHSAT034577 |
4 | lnc-SLITRK6-13 | chr13:87121092-87121362 | NONHSAT034578 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000212055 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1393272 | chr13:87116479-87116480 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs370745487 | chr13:87116497-87116498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370841698 | chr13:87116543-87116544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117555112 | chr13:87116593-87116594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374225040 | chr13:87116613-87116614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528083582 | chr13:87116618-87116619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs546239275 | chr13:87116651-87116652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528909501 | chr13:87116652-87116653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538825837 | chr13:87116655-87116656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551140675 | chr13:87116674-87116675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569380382 | chr13:87116705-87116706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559307971 | chr13:87116761-87116762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374405364 | chr13:87116782-87116783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138614191 | chr13:87116784-87116785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs111690917 | chr13:87116799-87116800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566832535 | chr13:87116864-87116865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116347869 | chr13:87116865-87116866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559067115 | chr13:87116876-87116877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577401266 | chr13:87116905-87116906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551456742 | chr13:87116945-87116946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571665091 | chr13:87117009-87117010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557115212 | chr13:87117027-87117028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575388867 | chr13:87117032-87117033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183627826 | chr13:87117038-87117039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188078464 | chr13:87117074-87117075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528047703 | chr13:87117092-87117093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368878995 | chr13:87117128-87117129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539855886 | chr13:87117142-87117143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564575890 | chr13:87117151-87117152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148876703 | chr13:87117154-87117155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547186275 | chr13:87117155-87117156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34654697 | chr13:87117175-87117176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78282310 | chr13:87117227-87117228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192729943 | chr13:87117353-87117354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565637901 | chr13:87117375-87117376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370973978 | chr13:87117383-87117384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536768452 | chr13:87117404-87117405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182148823 | chr13:87117505-87117506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186886095 | chr13:87117516-87117517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567193972 | chr13:87117526-87117527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534530687 | chr13:87117527-87117528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558969911 | chr13:87117540-87117541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143529230 | chr13:87117569-87117570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148700553 | chr13:87117587-87117588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141403305 | chr13:87117588-87117589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs386380065 | chr13:87117591-87117592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs56326366 | chr13:87117595-87117596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200926403 | chr13:87117596-87117597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201018974 | chr13:87117598-87117599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556389194 | chr13:87117611-87117612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:87116400-87117200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:87116800-87117000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr13:87117200-87118200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr13:87117200-87118200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr13:87118200-87118600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr13:87118200-87118600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr13:87118200-87118800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr13:87118200-87118800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr13:87118400-87118600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr13:87129000-87129200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr13:87129000-87129200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr13:87134200-87134800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr13:87134200-87134800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr13:87134200-87135600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr13:87134400-87135200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr13:87163000-87163600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr13:87193800-87195000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
18 | chr13:87194200-87194600 | Active TSS | HUES6 Cell Line | embryonic stem cell |
19 | chr13:87194200-87194600 | Active TSS | Hela-S3 | cervix |